NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Zymoptiq

Zymoptiq

Private
LezennesHealthcare & Life Scienceshttps://zymoptiq.com/

Last Round

VC Round

Jan 26, 2022

Total Funding Raised

$1.53M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Zymoptiq is a biotechnology company that provides an analytical tool to characterize, measure, and assay the activities of enzymes for various industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Sensors, Quality Management

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Usage-Based SaaS

AI Layer

Non-AI

Keywords

enzymatic activity measurementbiochemical analysisenzyme assaylab-on-a-chipbiotech sensorshigh-throughput screeningquality controlanalytical instrumentationin-situ testingbioprocess monitoringenzymatic sensorfood safety testingmetrological testingbiotech lab equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zymoptiq Comps

Public and private peers based on sector, stage, and business model.

Zymoptiq comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Zymoptiq Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 26, 2022
AcceleratorSep 16, 2019
GrantJan 29, 2019
Pre SeedJul 5, 2018

Key People

Founding team and executive leadership

Philippe Pebay

Cofounder - CEO

Founding Team

Zymoptiq Investors

Notable investors and investment history

Zymoptiq investors
InvestorRounds
BpifrancePre Seed, VC Round
FinorpaVC Round
Thia VenturesVC Round
StartLifeAccelerator
BpifranceVC Round
SATT NordGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Monthly visitors increased 2567% MoM, from 9 to 240.

Zymoptiq Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zymoptiq Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zymoptiq's valuation, stock price, and market status.

Firmographic Details

HeadquartersLezennes
Employee Range16
Year Founded2019
Last FundingJan 26, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.